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Pathogenesis and Molecular Biology of a Transmissible Tumor  in the Tasmanian Devil
The Tasmanian devil is threatened with extinction by a 
fatal transmissible cancer, Devil Facial Tumor Disease 
(DFTD). Since its emergence in 1996, DFTD has spread 
rapidly throughout the country, having incidences over 
than 80% in some populations with a 100% mortality rate; 
i.e. the effects are devastating. 
This neoplasm is unusual in that, contrary to widely held 
knowledge that cancer dies with its host, it has outlived 
its original host. 
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• Tumors on facial area develop into large multifocal
   masses resulting in a locally invasive neoplasm.
• Tumor size obstructs feeding resulting in starvation.
• Cytology and Histology studies result non-especific.
   However, IHQ techniques show that all tumor cells 
   stain positive for Periaxin, a Schwann cells specific
   marker.
• Cytogenetic shows that tumor karyotype is 
   different from constitutional karyotype. 
• In all cases tumor karyotype is identical, so it 
   confirms that DFTD is a transmissible cancer.
• Common anatomical location and the fighting behaviour suggest the possibility of 
   bite transmission. 
• Cytology studies confirm exfoliated tumor cells on canine teeth.
3.2. Tumor Implantation
• Keep insurance population for release in the event of wild extinction.
• Research to identify resistant genotypes in the MHC gene complex.
• Vaccine development as a long term solution. 
Disease Management5
Conclusions 6
• A singular infectious devil was the source of DFTD
• Transmission occurs due to intraspecific facial biting
• DFTD is a peripheral nerve sheath neoplasm of Shawnn cell origin
• Immune Response Escape Mechanisms are still unknown. Further research is necessary to
    identify new therapeutic targets
• Transmission is an interindividual metastasis process
• DFTD has illustrated the vulnerability of a population with limited genetic diversity
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Fig. 4. Fighting habits. From Ostrander et al. (2016)
4.3. Natural Killer (NK)
• Absense of MHC-I should make tumor cells targets for NK because 
   MHC-I is a ligand for the NK cell inhibitory receptor. But it doesn´t 
   occur and it is still unknown why. 
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3.1. Allograft Theory
Clonal transmission occurs by biting during social interaction
DFTD originated from a peripheral 
nerve sheath tumor
Fig. 2. DFTD Histology. From Bender et al. (2014) Fig. 3. DFTD IHQ. From Pye et al. (2016)
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• Initially, reduced genetic diversity was
   proposed to explain lack of allorecognition.
• Self/non-self recognition depends on 
   Lymphocyte T / MHC-I interaction.
         
• Genome sequencing confirms low genetic     
   diversity at MHC loci.
• However, skin allograft rejection is observed.
Depleted MHC diversity doesn´t 
explain lack of allorecognition 
4.1. Reduced genetic diversity 4.2. Downregulation MHC-I expression
Absence of MHC-I on cell surface 
allows DFTD to elude immune 
surveillance 
• Treatment with Histone Deacetylase 
   inhibitors (iHDAC) upregulates 
   expression of β2m, TAP1, TAP2.
Low expression of MHC-I is due to 
epigenetic regulation
Fig. 5. Skin graft betwen unrelated Tasmanian devils . Kreiss et al. (2011)
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• Gene expression analysis RT-PCR reveals
   low levels of β2m, TAP1, TAP2 that results
   in disruption to the assembly of MHC-I 
   and impariment of peptide transport.
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Fig.1. DFTD distribution in Tasmania. From Bender et al. (2014)
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Immune escape mechanisms 4
Normal Karyotype           Tumor Karyotype
 14 chromosomes            13 chromosomes 
             (4 mutated markers)
1      2            3            4      5           6         X  2        3      4          5             6        M1     M2     M3     M4
This bibliographic review 
aims to describe the 
molecular biology of this 
transmissible tumor 
especially focusing on 
transmission and the 
escape of the immune 
system response.
• IFN-γ treatment restores MHC-I on cell surface.  
• Immunization is based on MHC-I + inoculation. 
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